nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Gadoxetate—ABCC3—lung cancer	0.0163	1	CrCbGaD
Gadoversetamide—Asthenia—Irinotecan—lung cancer	0.000406	0.000413	CcSEcCtD
Gadoversetamide—Fatigue—Etoposide—lung cancer	0.000406	0.000413	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000406	0.000412	CcSEcCtD
Gadoversetamide—Pain—Etoposide—lung cancer	0.000403	0.00041	CcSEcCtD
Gadoversetamide—Constipation—Etoposide—lung cancer	0.000403	0.00041	CcSEcCtD
Gadoversetamide—Dysuria—Doxorubicin—lung cancer	0.000402	0.000409	CcSEcCtD
Gadoversetamide—Decreased appetite—Paclitaxel—lung cancer	0.000402	0.000408	CcSEcCtD
Gadoversetamide—Dry mouth—Docetaxel—lung cancer	0.0004	0.000406	CcSEcCtD
Gadoversetamide—Haemoglobin—Methotrexate—lung cancer	0.000399	0.000406	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000399	0.000406	CcSEcCtD
Gadoversetamide—Fatigue—Paclitaxel—lung cancer	0.000398	0.000405	CcSEcCtD
Gadoversetamide—Haemorrhage—Methotrexate—lung cancer	0.000397	0.000404	CcSEcCtD
Gadoversetamide—Asthenia—Gemcitabine—lung cancer	0.000396	0.000403	CcSEcCtD
Gadoversetamide—Constipation—Paclitaxel—lung cancer	0.000395	0.000402	CcSEcCtD
Gadoversetamide—Pain—Paclitaxel—lung cancer	0.000395	0.000402	CcSEcCtD
Gadoversetamide—Confusional state—Docetaxel—lung cancer	0.000395	0.000401	CcSEcCtD
Gadoversetamide—Pharyngitis—Methotrexate—lung cancer	0.000394	0.000401	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Methotrexate—lung cancer	0.000392	0.000399	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Docetaxel—lung cancer	0.000392	0.000398	CcSEcCtD
Gadoversetamide—Oedema—Docetaxel—lung cancer	0.000392	0.000398	CcSEcCtD
Gadoversetamide—Pruritus—Gemcitabine—lung cancer	0.00039	0.000397	CcSEcCtD
Gadoversetamide—Urethral disorder—Methotrexate—lung cancer	0.000389	0.000396	CcSEcCtD
Gadoversetamide—Feeling abnormal—Etoposide—lung cancer	0.000388	0.000395	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Doxorubicin—lung cancer	0.000388	0.000394	CcSEcCtD
Gadoversetamide—Diarrhoea—Irinotecan—lung cancer	0.000388	0.000394	CcSEcCtD
Gadoversetamide—Pneumonia—Doxorubicin—lung cancer	0.000385	0.000392	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Etoposide—lung cancer	0.000385	0.000392	CcSEcCtD
Gadoversetamide—Shock—Docetaxel—lung cancer	0.000385	0.000392	CcSEcCtD
Gadoversetamide—Nervous system disorder—Docetaxel—lung cancer	0.000384	0.00039	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Docetaxel—lung cancer	0.000383	0.00039	CcSEcCtD
Gadoversetamide—Tachycardia—Docetaxel—lung cancer	0.000382	0.000389	CcSEcCtD
Gadoversetamide—Feeling abnormal—Paclitaxel—lung cancer	0.000381	0.000387	CcSEcCtD
Gadoversetamide—Skin disorder—Docetaxel—lung cancer	0.00038	0.000387	CcSEcCtD
Gadoversetamide—Hypersensitivity—Cisplatin—lung cancer	0.000379	0.000385	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Paclitaxel—lung cancer	0.000378	0.000384	CcSEcCtD
Gadoversetamide—Diarrhoea—Gemcitabine—lung cancer	0.000378	0.000384	CcSEcCtD
Gadoversetamide—Erythema multiforme—Methotrexate—lung cancer	0.000376	0.000382	CcSEcCtD
Gadoversetamide—Dizziness—Irinotecan—lung cancer	0.000375	0.000381	CcSEcCtD
Gadoversetamide—Urticaria—Etoposide—lung cancer	0.000374	0.000381	CcSEcCtD
Gadoversetamide—Anorexia—Docetaxel—lung cancer	0.000373	0.000379	CcSEcCtD
Gadoversetamide—Abdominal pain—Etoposide—lung cancer	0.000373	0.000379	CcSEcCtD
Gadoversetamide—Body temperature increased—Etoposide—lung cancer	0.000373	0.000379	CcSEcCtD
Gadoversetamide—Conjunctivitis—Doxorubicin—lung cancer	0.000372	0.000379	CcSEcCtD
Gadoversetamide—Urinary tract infection—Doxorubicin—lung cancer	0.000372	0.000379	CcSEcCtD
Gadoversetamide—Eye disorder—Methotrexate—lung cancer	0.000371	0.000377	CcSEcCtD
Gadoversetamide—Tinnitus—Methotrexate—lung cancer	0.00037	0.000377	CcSEcCtD
Gadoversetamide—Asthenia—Cisplatin—lung cancer	0.000369	0.000375	CcSEcCtD
Gadoversetamide—Cardiac disorder—Methotrexate—lung cancer	0.000369	0.000375	CcSEcCtD
Gadoversetamide—Urticaria—Paclitaxel—lung cancer	0.000367	0.000373	CcSEcCtD
Gadoversetamide—Hypotension—Docetaxel—lung cancer	0.000366	0.000372	CcSEcCtD
Gadoversetamide—Haematuria—Doxorubicin—lung cancer	0.000365	0.000371	CcSEcCtD
Gadoversetamide—Abdominal pain—Paclitaxel—lung cancer	0.000365	0.000371	CcSEcCtD
Gadoversetamide—Body temperature increased—Paclitaxel—lung cancer	0.000365	0.000371	CcSEcCtD
Gadoversetamide—Epistaxis—Doxorubicin—lung cancer	0.000361	0.000367	CcSEcCtD
Gadoversetamide—Angiopathy—Methotrexate—lung cancer	0.00036	0.000366	CcSEcCtD
Gadoversetamide—Vomiting—Irinotecan—lung cancer	0.00036	0.000366	CcSEcCtD
Gadoversetamide—Sinusitis—Doxorubicin—lung cancer	0.00036	0.000365	CcSEcCtD
Gadoversetamide—Immune system disorder—Methotrexate—lung cancer	0.000359	0.000365	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Methotrexate—lung cancer	0.000358	0.000364	CcSEcCtD
Gadoversetamide—Rash—Irinotecan—lung cancer	0.000357	0.000363	CcSEcCtD
Gadoversetamide—Dermatitis—Irinotecan—lung cancer	0.000357	0.000363	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000357	0.000363	CcSEcCtD
Gadoversetamide—Chills—Methotrexate—lung cancer	0.000356	0.000362	CcSEcCtD
Gadoversetamide—Headache—Irinotecan—lung cancer	0.000355	0.000361	CcSEcCtD
Gadoversetamide—Insomnia—Docetaxel—lung cancer	0.000354	0.00036	CcSEcCtD
Gadoversetamide—Diarrhoea—Cisplatin—lung cancer	0.000352	0.000358	CcSEcCtD
Gadoversetamide—Paraesthesia—Docetaxel—lung cancer	0.000352	0.000357	CcSEcCtD
Gadoversetamide—Vomiting—Gemcitabine—lung cancer	0.000351	0.000357	CcSEcCtD
Gadoversetamide—Dyspnoea—Docetaxel—lung cancer	0.000349	0.000355	CcSEcCtD
Gadoversetamide—Somnolence—Docetaxel—lung cancer	0.000348	0.000354	CcSEcCtD
Gadoversetamide—Mental disorder—Methotrexate—lung cancer	0.000348	0.000354	CcSEcCtD
Gadoversetamide—Rash—Gemcitabine—lung cancer	0.000348	0.000354	CcSEcCtD
Gadoversetamide—Dermatitis—Gemcitabine—lung cancer	0.000348	0.000353	CcSEcCtD
Gadoversetamide—Hypersensitivity—Etoposide—lung cancer	0.000347	0.000353	CcSEcCtD
Gadoversetamide—Erythema—Methotrexate—lung cancer	0.000346	0.000352	CcSEcCtD
Gadoversetamide—Malnutrition—Methotrexate—lung cancer	0.000346	0.000352	CcSEcCtD
Gadoversetamide—Haemoglobin—Doxorubicin—lung cancer	0.000346	0.000351	CcSEcCtD
Gadoversetamide—Headache—Gemcitabine—lung cancer	0.000346	0.000351	CcSEcCtD
Gadoversetamide—Rhinitis—Doxorubicin—lung cancer	0.000345	0.000351	CcSEcCtD
Gadoversetamide—Dyspepsia—Docetaxel—lung cancer	0.000345	0.00035	CcSEcCtD
Gadoversetamide—Haemorrhage—Doxorubicin—lung cancer	0.000344	0.00035	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Doxorubicin—lung cancer	0.000342	0.000348	CcSEcCtD
Gadoversetamide—Pharyngitis—Doxorubicin—lung cancer	0.000341	0.000347	CcSEcCtD
Gadoversetamide—Decreased appetite—Docetaxel—lung cancer	0.00034	0.000346	CcSEcCtD
Gadoversetamide—Hypersensitivity—Paclitaxel—lung cancer	0.00034	0.000346	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Doxorubicin—lung cancer	0.00034	0.000345	CcSEcCtD
Gadoversetamide—Oedema peripheral—Doxorubicin—lung cancer	0.000339	0.000345	CcSEcCtD
Gadoversetamide—Dysgeusia—Methotrexate—lung cancer	0.000339	0.000344	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Docetaxel—lung cancer	0.000338	0.000344	CcSEcCtD
Gadoversetamide—Asthenia—Etoposide—lung cancer	0.000338	0.000344	CcSEcCtD
Gadoversetamide—Fatigue—Docetaxel—lung cancer	0.000338	0.000343	CcSEcCtD
Gadoversetamide—Urethral disorder—Doxorubicin—lung cancer	0.000337	0.000343	CcSEcCtD
Gadoversetamide—Nausea—Irinotecan—lung cancer	0.000337	0.000342	CcSEcCtD
Gadoversetamide—Pain—Docetaxel—lung cancer	0.000335	0.00034	CcSEcCtD
Gadoversetamide—Constipation—Docetaxel—lung cancer	0.000335	0.00034	CcSEcCtD
Gadoversetamide—Back pain—Methotrexate—lung cancer	0.000335	0.00034	CcSEcCtD
Gadoversetamide—Pruritus—Etoposide—lung cancer	0.000333	0.000339	CcSEcCtD
Gadoversetamide—Asthenia—Paclitaxel—lung cancer	0.000331	0.000337	CcSEcCtD
Gadoversetamide—Nausea—Gemcitabine—lung cancer	0.000328	0.000333	CcSEcCtD
Gadoversetamide—Vomiting—Cisplatin—lung cancer	0.000327	0.000332	CcSEcCtD
Gadoversetamide—Pruritus—Paclitaxel—lung cancer	0.000327	0.000332	CcSEcCtD
Gadoversetamide—Vision blurred—Methotrexate—lung cancer	0.000326	0.000331	CcSEcCtD
Gadoversetamide—Erythema multiforme—Doxorubicin—lung cancer	0.000325	0.000331	CcSEcCtD
Gadoversetamide—Rash—Cisplatin—lung cancer	0.000324	0.00033	CcSEcCtD
Gadoversetamide—Dermatitis—Cisplatin—lung cancer	0.000324	0.000329	CcSEcCtD
Gadoversetamide—Feeling abnormal—Docetaxel—lung cancer	0.000323	0.000328	CcSEcCtD
Gadoversetamide—Diarrhoea—Etoposide—lung cancer	0.000322	0.000328	CcSEcCtD
Gadoversetamide—Eye disorder—Doxorubicin—lung cancer	0.000321	0.000327	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Methotrexate—lung cancer	0.000321	0.000326	CcSEcCtD
Gadoversetamide—Tinnitus—Doxorubicin—lung cancer	0.000321	0.000326	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Docetaxel—lung cancer	0.00032	0.000326	CcSEcCtD
Gadoversetamide—Flushing—Doxorubicin—lung cancer	0.000319	0.000325	CcSEcCtD
Gadoversetamide—Cardiac disorder—Doxorubicin—lung cancer	0.000319	0.000325	CcSEcCtD
Gadoversetamide—Diarrhoea—Paclitaxel—lung cancer	0.000316	0.000321	CcSEcCtD
Gadoversetamide—Angiopathy—Doxorubicin—lung cancer	0.000312	0.000317	CcSEcCtD
Gadoversetamide—Malaise—Methotrexate—lung cancer	0.000312	0.000317	CcSEcCtD
Gadoversetamide—Dizziness—Etoposide—lung cancer	0.000312	0.000317	CcSEcCtD
Gadoversetamide—Immune system disorder—Doxorubicin—lung cancer	0.000311	0.000316	CcSEcCtD
Gadoversetamide—Vertigo—Methotrexate—lung cancer	0.000311	0.000316	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Doxorubicin—lung cancer	0.00031	0.000315	CcSEcCtD
Gadoversetamide—Body temperature increased—Docetaxel—lung cancer	0.00031	0.000315	CcSEcCtD
Gadoversetamide—Abdominal pain—Docetaxel—lung cancer	0.00031	0.000315	CcSEcCtD
Gadoversetamide—Chills—Doxorubicin—lung cancer	0.000309	0.000314	CcSEcCtD
Gadoversetamide—Arrhythmia—Doxorubicin—lung cancer	0.000307	0.000312	CcSEcCtD
Gadoversetamide—Dizziness—Paclitaxel—lung cancer	0.000306	0.000311	CcSEcCtD
Gadoversetamide—Nausea—Cisplatin—lung cancer	0.000306	0.000311	CcSEcCtD
Gadoversetamide—Cough—Methotrexate—lung cancer	0.000302	0.000307	CcSEcCtD
Gadoversetamide—Mental disorder—Doxorubicin—lung cancer	0.000301	0.000306	CcSEcCtD
Gadoversetamide—Convulsion—Methotrexate—lung cancer	0.0003	0.000305	CcSEcCtD
Gadoversetamide—Vomiting—Etoposide—lung cancer	0.0003	0.000305	CcSEcCtD
Gadoversetamide—Malnutrition—Doxorubicin—lung cancer	0.000299	0.000304	CcSEcCtD
Gadoversetamide—Erythema—Doxorubicin—lung cancer	0.000299	0.000304	CcSEcCtD
Gadoversetamide—Rash—Etoposide—lung cancer	0.000297	0.000302	CcSEcCtD
Gadoversetamide—Dermatitis—Etoposide—lung cancer	0.000297	0.000302	CcSEcCtD
Gadoversetamide—Headache—Etoposide—lung cancer	0.000295	0.0003	CcSEcCtD
Gadoversetamide—Flatulence—Doxorubicin—lung cancer	0.000295	0.0003	CcSEcCtD
Gadoversetamide—Chest pain—Methotrexate—lung cancer	0.000294	0.000299	CcSEcCtD
Gadoversetamide—Myalgia—Methotrexate—lung cancer	0.000294	0.000299	CcSEcCtD
Gadoversetamide—Arthralgia—Methotrexate—lung cancer	0.000294	0.000299	CcSEcCtD
Gadoversetamide—Tension—Doxorubicin—lung cancer	0.000294	0.000299	CcSEcCtD
Gadoversetamide—Vomiting—Paclitaxel—lung cancer	0.000294	0.000299	CcSEcCtD
Gadoversetamide—Dysgeusia—Doxorubicin—lung cancer	0.000293	0.000298	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000292	0.000297	CcSEcCtD
Gadoversetamide—Rash—Paclitaxel—lung cancer	0.000291	0.000296	CcSEcCtD
Gadoversetamide—Dermatitis—Paclitaxel—lung cancer	0.000291	0.000296	CcSEcCtD
Gadoversetamide—Discomfort—Methotrexate—lung cancer	0.000291	0.000296	CcSEcCtD
Gadoversetamide—Nervousness—Doxorubicin—lung cancer	0.000291	0.000296	CcSEcCtD
Gadoversetamide—Back pain—Doxorubicin—lung cancer	0.00029	0.000294	CcSEcCtD
Gadoversetamide—Headache—Paclitaxel—lung cancer	0.000289	0.000294	CcSEcCtD
Gadoversetamide—Hypersensitivity—Docetaxel—lung cancer	0.000289	0.000293	CcSEcCtD
Gadoversetamide—Muscle spasms—Doxorubicin—lung cancer	0.000288	0.000293	CcSEcCtD
Gadoversetamide—Confusional state—Methotrexate—lung cancer	0.000285	0.000289	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Methotrexate—lung cancer	0.000282	0.000287	CcSEcCtD
Gadoversetamide—Vision blurred—Doxorubicin—lung cancer	0.000282	0.000287	CcSEcCtD
Gadoversetamide—Asthenia—Docetaxel—lung cancer	0.000281	0.000286	CcSEcCtD
Gadoversetamide—Nausea—Etoposide—lung cancer	0.00028	0.000285	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Doxorubicin—lung cancer	0.000278	0.000282	CcSEcCtD
Gadoversetamide—Pruritus—Docetaxel—lung cancer	0.000277	0.000282	CcSEcCtD
Gadoversetamide—Nervous system disorder—Methotrexate—lung cancer	0.000277	0.000281	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Methotrexate—lung cancer	0.000276	0.000281	CcSEcCtD
Gadoversetamide—Agitation—Doxorubicin—lung cancer	0.000275	0.00028	CcSEcCtD
Gadoversetamide—Nausea—Paclitaxel—lung cancer	0.000274	0.000279	CcSEcCtD
Gadoversetamide—Skin disorder—Methotrexate—lung cancer	0.000274	0.000279	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Methotrexate—lung cancer	0.000273	0.000277	CcSEcCtD
Gadoversetamide—Malaise—Doxorubicin—lung cancer	0.00027	0.000275	CcSEcCtD
Gadoversetamide—Vertigo—Doxorubicin—lung cancer	0.000269	0.000274	CcSEcCtD
Gadoversetamide—Anorexia—Methotrexate—lung cancer	0.000269	0.000274	CcSEcCtD
Gadoversetamide—Syncope—Doxorubicin—lung cancer	0.000269	0.000273	CcSEcCtD
Gadoversetamide—Diarrhoea—Docetaxel—lung cancer	0.000268	0.000272	CcSEcCtD
Gadoversetamide—Palpitations—Doxorubicin—lung cancer	0.000265	0.000269	CcSEcCtD
Gadoversetamide—Hypotension—Methotrexate—lung cancer	0.000264	0.000268	CcSEcCtD
Gadoversetamide—Loss of consciousness—Doxorubicin—lung cancer	0.000263	0.000268	CcSEcCtD
Gadoversetamide—Cough—Doxorubicin—lung cancer	0.000261	0.000266	CcSEcCtD
Gadoversetamide—Convulsion—Doxorubicin—lung cancer	0.000259	0.000264	CcSEcCtD
Gadoversetamide—Dizziness—Docetaxel—lung cancer	0.000259	0.000263	CcSEcCtD
Gadoversetamide—Hypertension—Doxorubicin—lung cancer	0.000259	0.000263	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000257	0.000261	CcSEcCtD
Gadoversetamide—Insomnia—Methotrexate—lung cancer	0.000255	0.00026	CcSEcCtD
Gadoversetamide—Myalgia—Doxorubicin—lung cancer	0.000255	0.000259	CcSEcCtD
Gadoversetamide—Arthralgia—Doxorubicin—lung cancer	0.000255	0.000259	CcSEcCtD
Gadoversetamide—Chest pain—Doxorubicin—lung cancer	0.000255	0.000259	CcSEcCtD
Gadoversetamide—Anxiety—Doxorubicin—lung cancer	0.000254	0.000258	CcSEcCtD
Gadoversetamide—Paraesthesia—Methotrexate—lung cancer	0.000253	0.000258	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000253	0.000257	CcSEcCtD
Gadoversetamide—Discomfort—Doxorubicin—lung cancer	0.000252	0.000256	CcSEcCtD
Gadoversetamide—Dyspnoea—Methotrexate—lung cancer	0.000252	0.000256	CcSEcCtD
Gadoversetamide—Somnolence—Methotrexate—lung cancer	0.000251	0.000255	CcSEcCtD
Gadoversetamide—Dry mouth—Doxorubicin—lung cancer	0.000249	0.000253	CcSEcCtD
Gadoversetamide—Vomiting—Docetaxel—lung cancer	0.000249	0.000253	CcSEcCtD
Gadoversetamide—Dyspepsia—Methotrexate—lung cancer	0.000248	0.000253	CcSEcCtD
Gadoversetamide—Rash—Docetaxel—lung cancer	0.000247	0.000251	CcSEcCtD
Gadoversetamide—Dermatitis—Docetaxel—lung cancer	0.000247	0.000251	CcSEcCtD
Gadoversetamide—Confusional state—Doxorubicin—lung cancer	0.000246	0.000251	CcSEcCtD
Gadoversetamide—Decreased appetite—Methotrexate—lung cancer	0.000245	0.000249	CcSEcCtD
Gadoversetamide—Headache—Docetaxel—lung cancer	0.000245	0.000249	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Doxorubicin—lung cancer	0.000244	0.000248	CcSEcCtD
Gadoversetamide—Oedema—Doxorubicin—lung cancer	0.000244	0.000248	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Methotrexate—lung cancer	0.000244	0.000248	CcSEcCtD
Gadoversetamide—Fatigue—Methotrexate—lung cancer	0.000243	0.000247	CcSEcCtD
Gadoversetamide—Pain—Methotrexate—lung cancer	0.000241	0.000245	CcSEcCtD
Gadoversetamide—Shock—Doxorubicin—lung cancer	0.00024	0.000244	CcSEcCtD
Gadoversetamide—Nervous system disorder—Doxorubicin—lung cancer	0.00024	0.000244	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Doxorubicin—lung cancer	0.000239	0.000243	CcSEcCtD
Gadoversetamide—Tachycardia—Doxorubicin—lung cancer	0.000239	0.000242	CcSEcCtD
Gadoversetamide—Skin disorder—Doxorubicin—lung cancer	0.000237	0.000241	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Doxorubicin—lung cancer	0.000236	0.00024	CcSEcCtD
Gadoversetamide—Anorexia—Doxorubicin—lung cancer	0.000233	0.000237	CcSEcCtD
Gadoversetamide—Nausea—Docetaxel—lung cancer	0.000233	0.000236	CcSEcCtD
Gadoversetamide—Feeling abnormal—Methotrexate—lung cancer	0.000233	0.000236	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Methotrexate—lung cancer	0.000231	0.000235	CcSEcCtD
Gadoversetamide—Hypotension—Doxorubicin—lung cancer	0.000228	0.000232	CcSEcCtD
Gadoversetamide—Urticaria—Methotrexate—lung cancer	0.000224	0.000228	CcSEcCtD
Gadoversetamide—Body temperature increased—Methotrexate—lung cancer	0.000223	0.000227	CcSEcCtD
Gadoversetamide—Abdominal pain—Methotrexate—lung cancer	0.000223	0.000227	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000223	0.000226	CcSEcCtD
Gadoversetamide—Insomnia—Doxorubicin—lung cancer	0.000221	0.000225	CcSEcCtD
Gadoversetamide—Paraesthesia—Doxorubicin—lung cancer	0.000219	0.000223	CcSEcCtD
Gadoversetamide—Dyspnoea—Doxorubicin—lung cancer	0.000218	0.000222	CcSEcCtD
Gadoversetamide—Somnolence—Doxorubicin—lung cancer	0.000217	0.000221	CcSEcCtD
Gadoversetamide—Dyspepsia—Doxorubicin—lung cancer	0.000215	0.000219	CcSEcCtD
Gadoversetamide—Decreased appetite—Doxorubicin—lung cancer	0.000212	0.000216	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000211	0.000215	CcSEcCtD
Gadoversetamide—Fatigue—Doxorubicin—lung cancer	0.000211	0.000214	CcSEcCtD
Gadoversetamide—Pain—Doxorubicin—lung cancer	0.000209	0.000212	CcSEcCtD
Gadoversetamide—Constipation—Doxorubicin—lung cancer	0.000209	0.000212	CcSEcCtD
Gadoversetamide—Hypersensitivity—Methotrexate—lung cancer	0.000208	0.000211	CcSEcCtD
Gadoversetamide—Asthenia—Methotrexate—lung cancer	0.000203	0.000206	CcSEcCtD
Gadoversetamide—Feeling abnormal—Doxorubicin—lung cancer	0.000201	0.000205	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Doxorubicin—lung cancer	0.0002	0.000203	CcSEcCtD
Gadoversetamide—Pruritus—Methotrexate—lung cancer	0.0002	0.000203	CcSEcCtD
Gadoversetamide—Urticaria—Doxorubicin—lung cancer	0.000194	0.000197	CcSEcCtD
Gadoversetamide—Abdominal pain—Doxorubicin—lung cancer	0.000193	0.000196	CcSEcCtD
Gadoversetamide—Body temperature increased—Doxorubicin—lung cancer	0.000193	0.000196	CcSEcCtD
Gadoversetamide—Diarrhoea—Methotrexate—lung cancer	0.000193	0.000196	CcSEcCtD
Gadoversetamide—Dizziness—Methotrexate—lung cancer	0.000187	0.00019	CcSEcCtD
Gadoversetamide—Hypersensitivity—Doxorubicin—lung cancer	0.00018	0.000183	CcSEcCtD
Gadoversetamide—Vomiting—Methotrexate—lung cancer	0.000179	0.000182	CcSEcCtD
Gadoversetamide—Rash—Methotrexate—lung cancer	0.000178	0.000181	CcSEcCtD
Gadoversetamide—Dermatitis—Methotrexate—lung cancer	0.000178	0.000181	CcSEcCtD
Gadoversetamide—Headache—Methotrexate—lung cancer	0.000177	0.00018	CcSEcCtD
Gadoversetamide—Asthenia—Doxorubicin—lung cancer	0.000175	0.000178	CcSEcCtD
Gadoversetamide—Pruritus—Doxorubicin—lung cancer	0.000173	0.000176	CcSEcCtD
Gadoversetamide—Nausea—Methotrexate—lung cancer	0.000168	0.00017	CcSEcCtD
Gadoversetamide—Diarrhoea—Doxorubicin—lung cancer	0.000167	0.00017	CcSEcCtD
Gadoversetamide—Dizziness—Doxorubicin—lung cancer	0.000162	0.000164	CcSEcCtD
Gadoversetamide—Vomiting—Doxorubicin—lung cancer	0.000155	0.000158	CcSEcCtD
Gadoversetamide—Rash—Doxorubicin—lung cancer	0.000154	0.000157	CcSEcCtD
Gadoversetamide—Dermatitis—Doxorubicin—lung cancer	0.000154	0.000157	CcSEcCtD
Gadoversetamide—Headache—Doxorubicin—lung cancer	0.000153	0.000156	CcSEcCtD
Gadoversetamide—Nausea—Doxorubicin—lung cancer	0.000145	0.000148	CcSEcCtD
